FrancophonIA/ELRC3.0 huggingface dataset:
English: The full EPAR for Lyxumia can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Lyxumia je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Allergic reactions have been reported in less than 1 in 100 patients using Lyxumia.
Slovenian: Alergijske reakcije so bile opažene pri manj kot 1 od 100 bolnikov, ki so uporabljali zdravilo Lyxumia.
English: This is a summary of the European public assessment report (EPAR) for Lyxumia.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Lyxumia.
English: What measures are being taken to ensure the safe and effective use of Lyxumia?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Lyxumia?
English: Adding Lyxumia to metformin is not associated with this risk.
Slovenian: Uporaba zdravila Lyxumia skupaj z metforminom ni povezana s tem tveganjem.
English: Lyxumia has been studied in seven main studies involving 3,825 adults with type 2 diabetes.
Slovenian: Zdravilo Lyxumia so proučevali v sedmih glavnih študijah, v katere je bilo vključenih 3 825 odraslih s sladkorno boleznijo tipa 2.
English: For more information about treatment with Lyxumia, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Lyxumia preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Other information about Lyxumia
Slovenian: Druge informacije o zdravilu Lyxumia
English: A risk management plan has been developed to ensure that Lyxumia is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Lyxumia je bil pripravljen načrt obvladovanja tveganj.
English: The CHMP concluded that the benefits of Lyxumia outweigh its risks and recommended that it be granted marketing authorisation.
Slovenian: CHMP je zaključil, da so koristi zdravila Lyxumia večje od z njim povezanih tveganj, in priporočil, da se zanj izda dovoljenje za promet.
English: Lyxumia lixisenatide
Slovenian: Lyxumia liksisenatid
English: What benefit has Lyxumia shown during the studies?
Slovenian: Kakšne koristi je zdravilo Lyxumia izkazalo med študijami?
English: HbA1c gives an indication of how well the blood glucose is controlled.
Slovenian: HbA1c kaže, kako dobro je glukoza v krvi uravnavana.
English: All of the studies measured the change in the level of glycosylated haemoglobin (HbA1c), which is the percentage of haemoglobin in the blood that has glucose attached.
Slovenian: V vseh študijah so merili spremembo ravni glikoziliranega hemoglobina (HbA1c), kar je odstotek hemoglobina v krvi, na katerega je vezana glukoza.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Lyxumia.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil to zdravilo, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: Lyxumia is started at a dose of 10 micrograms once a day which is increased to 20 micrograms once a day after 14 days.
Slovenian: Zdravilo Lyxumia se daje najprej enkrat na dan v 10-mikrogramskem odmerku, ki se po 14 dneh poviša na 20 mikrogramov enkrat na dan.
English: Lyxumia was more effective than placebo at controlling blood glucose.
Slovenian: Zdravilo Lyxumia je bilo učinkovitejše od placeba pri uravnavanju glukoze v krvi.
English: It works by attaching to glucagon-like peptide 1 (GLP-1) receptors that are found on the surface of the cells in the pancreas and that cause the production of insulin by the pancreas.
Slovenian: Deluje tako, da se veže na receptorje glukagonu podobnih peptidov 1 (GLP-1), ki se nahajajo na površini celic trebušne slinavke in ki sprožajo proizvodnjo insulina v njej.
English: For the full list of all side effects and restrictions with Lyxumia, see the package leaflet.
Slovenian: Za celoten seznam vseh neželenih učinkov in omejitev pri uporabi zdravila Lyxumia glejte navodilo za uporabo.
English: It is available as a solution for injection in a pre-filled pen that provides either 10 micrograms or 20 micrograms of lixisenatide in each dose.
Slovenian: Na voljo je v obliki raztopine za injiciranje v predhodno napolnjenih peresnikih, ki v vsakem odmerku vsebujejo 10 ali 20 mikrogramov liksisenatida.
English: When Lyxumia is injected, lixisenatide reaches the receptors in the pancreas and activates them.
Slovenian: Pri injiciranju zdravila Lyxumia liksisenatid doseže receptorje v trebušni slinavki in jih sproži.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Lyxumia, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti tega zdravila in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: The most common side effects with Lyxumia (seen in more than 1 patient in 10) are nausea (feeling sick), vomiting, diarrhoea and headache.
Slovenian: Najpogostejši neželeni učinki zdravila Lyxumia (opaženi pri 1 bolniku od 10) so navzeja (slabost), bruhanje, driska in glavobol.
English: Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively.
Slovenian: Sladkorna bolezen tipa 2 je bolezen, pri kateri trebušna slinavka ne tvori dovolj insulina za uravnavanje ravni glukoze v krvi ali pri kateri telo insulina ne more učinkovito izrabiti.
English: The study comparing Lyxumia with exenatide (added to metformin) showed reduced HbA1c levels by 0.79% after 24 weeks treatment with Lyxumia compared to 0.96% with exenatide twice daily.
Slovenian: Študija, v kateri so primerjali zdravilo Lyxumia z eksenatidom, dodanim metforminu, je pokazala, da se je raven HbA1c znižala za 0,79 % po 24 tednih zdravljenja z zdravilom Lyxumia v primerjavi z 0,96 % pri zdravljenju z eksenatidom, dajanim dvakrat na dan.
English: What is the risk associated with Lyxumia?
Slovenian: Kakšna tveganja so povezana z zdravilom Lyxumia?
English: Lyxumia is a diabetes medicine that contains the active substance lixisenatide.
Slovenian: Lyxumia je zdravilo za sladkorno bolezen, ki vsebuje zdravilno učinkovino liksisenatid.
English: It is used together with diabetes medicines taken by mouth and/or basal insulin (long-acting insulin) in patients whose blood glucose levels are not adequately controlled by these medicines together with diet and exercise.
Slovenian: Uporablja se skupaj z zdravili za zdravljenje sladkorne bolezni, ki se jemljejo peroralno in/ali bazalnim insulinom (insulin z dolgotrajnim delovanjem) pri bolnikih, pri katerih ravni glukoze v krvi niso zadostno nadzorovane s temi zdravili, v kombinaciji z ustrezno prehrano in telesno dejavnostjo.
English: If the patient is already taking a sulphonylurea (another diabetes medicine) or basal insulin, the doctor may need to reduce the dose of the sulphonylurea or basal insulin because there is a risk of hypoglycaemia (low blood sugar levels).
Slovenian: Če bolnik že prejema sulfonilsečnino (drugo zdravilo proti sladkorni bolezni) ali bazalni insulin, mora zdravnik njun odmerek zmanjšati, ker obstaja tveganje za pojav hipoglikemije (nizke ravni sladkorja v krvi).
English: It is given as an injection under the skin in the abdominal wall (at the front of the waist), upper arm or thigh.
Slovenian: Injicira se pod kožo v trebušno steno (sprednji del pasu), nadlaket ali stegno.
English: Lyxumia should not be given with a combination of both, basal insulin and a sulphonylurea.
Slovenian: Zdravila Lyxumia naj ne bi dajali skupaj s kombinacijo obeh drugih zdravil, bazalnega insulina in sulfonilsečnine.
English: Six of the studies compared Lyxumia with placebo (a dummy treatment), used alone or when added to metformin, a sulphonylurea, basal insulin, or a combination of two of these medicines, in patients in whom previous treatment had failed.
Slovenian: V šestih študijah so zdravilo Lyxumia primerjali s placebom (zdravilom brez zdravilne učinkovine), kadar se je to uporabljalo kot samostojno zdravilo ali kot dodatek metforminu, sulfonilsečnini ali bazalnemu insulinu, ali kombinaciji dveh od teh zdravil, pri bolnikih, pri katerih predhodno zdravljenje ni bilo uspešno.
English: When used on its own, Lyxumia reduced Hb1Ac levels by 0.6% more than placebo.
Slovenian: Pri samostojni uporabi je zmanjšalo vrednosti Hb1Ac za 0,6 % več kot placebo.
English: In one study, Lyxumia was compared with another diabetes medicine called exenatide when added to metformin in patients whose blood sugar levels were not adequately controlled by metformin.
Slovenian: V eni študiji so zdravilo Lyxumia primerjali z drugim zdravilom za zdravljenje sladkorne bolezni, eksenatidom, dodanim metforminu, pri bolnikih, katerih raven krvnega sladkorja ni bila ustrezno nadzorovana z metforminom.
English: Regarding its safety, most side effects are comparable to those of other similar diabetes medicines with side effects affecting the gut being the most common ones.
Slovenian: Glede varnosti zdravila je odbor ugotovil, da je večina njegovih neželenih učinkov primerljivih z neželenimi učinki drugih podobnih zdravil za zdravljenje sladkorne bolezni, ki so najpogosteje prizadeli črevesje.
English: When used in combination with other diabetes medicines, Lyxumia reduced Hb1Ac levels by 0.4 up to 0.9% more than placebo.
Slovenian: V kombinaciji z drugimi zdravili za zdravljenje sladkorne bolezni je zdravilo Lyxumia zmanjšalo raven Hb1Ac za 0,4 do 0,9 % bolj kot placebo.
English: Why has Lyxumia been approved?
Slovenian: Zakaj je bilo zdravilo Lyxumia odobreno?
English: In addition, beneficial weight loss was seen in patients treated with Lyxumia.
Slovenian: Poleg tega je bila opažena dobrodošla izguba telesne mase pri zdravljenih bolnikih.
English: The active substance in Lyxumia, lixisenatide, is a ‘GLP-1 receptor agonist'.
Slovenian: Zdravilna učinkovina v zdravilu Lyxumia, liksisenatid, je agonist receptorjev glukagonu podobnega peptida 1 (GLP-1).
English: HbA1c levels were measured after 12 weeks when Lyxumia was used alone and after 24 weeks when it was used in combination with other diabetes medicines.
Slovenian: Te ravni so merili po 12 tednih, kadar se je zdravilo Lyxumia uporabljalo kot samostojno zdravilo, in po 24 tednih, ko so to zdravilo uporabili skupaj z drugimi zdravili za zdravljenje sladkorne bolezni.
English: This causes the release of insulin and helps to reduce blood glucose levels and control type 2 diabetes.
Slovenian: Tako se izloči insulin, ki pomaga znižati raven glukoze v krvi in tako nadzoruje sladkorno bolezen tipa 2.
English: Lyxumia is used in adults who have type 2 diabetes to control their blood glucose (sugar) level.
Slovenian: Zdravilo Lyxumia se uporablja za zdravljenje odraslih bolnikov s sladkorno boleznijo tipa 2 za uravnavanje ravni glukoze (sladkorja) v krvi.
English: The CHMP concluded that Lyxumia was shown to be effective at lowering blood glucose levels in patients with type 2 diabetes, when given alone or in combination with other diabetes medicines.
Slovenian: CHMP je zaključil, da se je zdravilo Lyxumia samostojno ali v kombinaciji z drugimi zdravili za zdravljenje sladkorne bolezni izkazalo za učinkovito pri zniževanju ravni glukoze v krvi pri bolnikih s sladkorno boleznijo tipa 2.
English: What is Lyxumia used for?
Slovenian: Za kaj se zdravilo Lyxumia uporablja?
English: What is Lyxumia?
Slovenian: Kaj je zdravilo Lyxumia?
English: When used together with a sulphonylurea or basal insulin, the most common side effect (seen in more than 1 patient in 10) is hypoglycaemia (low blood glucose levels).
Slovenian: Najpogostejši neželeni učinek zdravila Lyxumia (opažen pri več kot 1 bolniku od 10) pri uporabi skupaj s sulfonilsečnino ali bazalnim insulinom je hipoglikemija (nizka raven glukoze v krvi).
English: How has Lyxumia been studied?
Slovenian: Kako je bilo zdravilo Lyxumia raziskano?
English: How is Lyxumia used?
Slovenian: Kako se zdravilo Lyxumia uporablja?
English: How does Lyxumia work?
Slovenian: Kako zdravilo Lyxumia deluje?
English: Intravenous use Powder: vial (glass) Solvent: pre-filled syringe (glass)
Slovenian: Velikost pakiranja prašek: viala (steklo); vehikel: napolnjena injekcijska brizga
English: Pack size
Slovenian: (steklo)
English: EG LABOLaboratoires Eurogenerics
Slovenian: Francija EG LABOLaboratoires Eurogenerics
English: Laboratórios Basi - Indústria Farm
Slovenian: Portugalska Laboratórios Basi - Indústria Farm
English: Annex Ia: Medicinal products recommended for maintenance and marketing authorisation applications for which bioequivalence vis-à-vis the EU reference medicinal product has been established
Slovenian: Priloga Ia: Zdravila, priporočena za ohranitev, in vloge za pridobitev dovoljenja za promet z zdravilom, za katera je bila ugotovljena biološka enakovrednost z referenčnim zdravilom, odobrenim v EU
English: Baclofeno Generis baclofen
Slovenian: Baclofeno Generis baklofen
English: Hexal AG, Germany
Slovenian: Nemčija Hexal AG, Germany
English: Sanofi Aventis France
Slovenian: Francija Sanofi Aventis France
English: QUALIGEN, SL
Slovenian: Španija QUALIGEN, SL
English: Teva Sante
Slovenian: Francija Teva Sante
English: ZYDUS France
Slovenian: Francija ZYDUS France
English: Belgium Sandoz n.v./s.a.
Slovenian: Belgija Sandoz n.v./s.a.
English: Annex Ib: Products for which the marketing authorisations are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation
Slovenian: Priloga Ib: Zdravila, za katere se priporoča začasni umik dovoljenja za promet z zdravilom, in vloge za pridobitev dovoljenja za promet z zdravilom, ki ne ustrezajo merilom za pridobitev dovoljenja
English: LABORATORIOS COMBIX, SLU
Slovenian: Španija LABORATORIOS COMBIX, SLU
English: tianeptine
Slovenian: tianeptin
English: SUBSTIPHARM DEVELOPPEMENT
Slovenian: SUBSTIPHARM DEVELOPPEMEN T
English: Belfada aripiprazole
Slovenian: Belfada aripiprazol
English: Loperamid Evolan loperamide
Slovenian: Loperamid Evolan loperamid
English: Sandoz A/S, Denmark
Slovenian: Finska Sandoz A/S, Denmark
English: United Kingdom Lupin (Europe) Limited
Slovenian: Lupin (Europe) Limited
English: Corporation Orion Pharma, Finland
Slovenian: Finska Orion Corporation Orion Pharma, Finland
English: Metoklopramid Alternova metoclopramide
Slovenian: Metoklopramid Alternova metoklopramid
English: United Kingdom Strides Arcolab International
Slovenian: Španija Strides Arcolab International
English: United Kingdom Kinedexe UK Limited (previously
Slovenian: Kinedexe UK Limited (previously NRIM Limited)
English: Loperamid Orifarm loperamide
Slovenian: Loperamid Orifarm loperamid
English: The Netherlands Sandoz B.V.
Slovenian: Nizozemska Sandoz B.V.
English: Alternova A/S Hydrokortison Alternova hydrocortisone
Slovenian: Alternova A/S Hydrokortison Alternova hidrokortizon
English: United Kingdom Medreich PLC
Slovenian: Medreich PLC
English: Alternova A/S Baklofen Alternova baclofen
Slovenian: Alternova A/S Baklofen Alternova baklofen
English: Alternova A/S Etodolac Alternova etodolac
Slovenian: Alternova A/S Etodolac Alternova etodolak
English: SANDOZ FARMACEUTICA, SA
Slovenian: Španija SANDOZ FARMACEUTICA , SA
English: hydrocortisone
Slovenian: hidrokortizon
English: Loperamid Apofri loperamide
Slovenian: Loperamid Apofri loperamid
English: 0.03 mg / 0.125 mg
Slovenian: 0,03 mg/0,125 m g
English: AUROVITAS SPAIN, SAU
Slovenian: Španija AUROVITAS SPAIN, SAU
English: Morysa memantine
Slovenian: Morysa memantin
English: VITAMA S.A.
Slovenian: Poljska VITAMA S.A.
English: Sodium Cromoglicate 100mg hard Capsules sodium cromoglicate 100 mg Capsule, hard Oral use
Slovenian: Sodium Cromoglicate 100mg hard Capsules natrijev kromoglikat kapsula, trda peroraln a uporaba
English: Bendro-flumetiazid Alternova bendro-flumethiazide 2.5 mg Tablet
Slovenian: Bendro-flumetiazid Alternova bendroflumetiazid 2,5 mg tableta peroralna uporaba
English: ethinylestradiol / levonorgestrel
Slovenian: etinilestradiol/levonorgestre l
English: Carbocisteine 375 mg Capsules, Hard carbocisteine
Slovenian: Carbocisteine 375 mg Capsules, Hard karbocistein kapsula, trda peroraln a uporaba
English: United Kingdom Dawa Limited
Slovenian: Dawa Limited
English: Memantine Pharmascope memantine
Slovenian: Memantine Pharmascope memantin
English: Prednisolon Alternova prednisolone
Slovenian: Prednisolon Alternova prednizolon
English: Mylan SAS
Slovenian: Francija Mylan SAS
English: The Netherlands Pharmascope Ltd.
Slovenian: Nizozemska Pharmascope Ltd.
English: Arrow Génériques
Slovenian: Francija Arrow Génériques
English: United Kingdom Milpharm Limited
Slovenian: Milpharm Limited
English: voriconazol
Slovenian: vorikonazol
English: Omega 3-acid-ethyl esters 1000mg soft capsules omega-3-acid-ethyl esters 90
Slovenian: Omega 3-acid-ethyl esters 1000mg soft capsules omega-3-kislinski etilestri kapsula, mehka
English: memantine
Slovenian: memantin
English: Naproxen Orion
Slovenian: Naproxen Orion naproksen
English: 2care4 Generics ApS
Slovenian: Švedska 2care4 Generics ApS
English: Mylan Dura GmbH
Slovenian: Nemčija Mylan Dura GmbH
English: Bupropion 1A Pharma 300 mg - Tablette mit veränderter Wirkstofffreisetzung bupropion
Slovenian: Bupropion 1A Pharma 300 mg - Tablette mit veränderter Wirkstofffreisetzung bupropion tableta s prirejenim sproščanjem
English: Medreich PLC Gliclazide 40 mg tablets gliclazide
Slovenian: Medreich PLC Gliclazide 40 mg tablets gliklazid
English: Hydroxyzine hydrochloride 25mg film-coated tablets hydroxyzine hydrochloride
Slovenian: Hydroxyzine hydrochloride 25mg film-coated tablets hidroksizinijev hidroklorid 25 mg
English: Aurobindo Pharma Ltd, Malta
Slovenian: Finska Aurobindo Pharma Ltd, Malta
English: Glob Ltd.
Slovenian: Portugalska Glob Ltd.
English: Belgium Aurobindo Pharma BV
Slovenian: Belgija Aurobindo Pharma BV
English: 1A Pharma GmbH
Slovenian: Avstrija 1A Pharma GmbH
English: Bupropion HCl Sandoz retard 300 mg, tabletten met gereguleerde afgifte bupropion
Slovenian: Bupropion HCl Sandoz retard 300 mg, tabletten met gereguleerde afgifte bupropion tableta s prirejenim sproščanjem
English: Maexeni 150/30 microgram Film Coated Tablets ethinylestradiol / levonorgestrel
Slovenian: Maexeni 150/30 microgram Film Coated Tablets etinilestradiol/levonorgestre l
English: Gliclazide 80mg Tablets gliclazide
Slovenian: Gliclazide 80mg Tablets gliklazid
English: Biogaran hydroxyzine BIOGARAN hydroxyzine
Slovenian: Francija Biogaran hydroxyzine BIOGARAN hidroksizin
English: loperamide
Slovenian: loperamid
English: Generis Farmacêutica, S.A.
Slovenian: Portugalska Generis Farmacêutica, S.A.
English: Esters ethyliques d'acides omega-3 Strides omega-3-acid-ethyl esters 90
Slovenian: Esters ethyliques d'acides omega-3 Strides omega-3-kislinski etilestri
English: Gliclazide 40mg Tablets gliclazide
Slovenian: Gliclazide 40mg Tablets gliklazid
English: Sandoz A/S
Slovenian: Švedska Sandoz A/S
English: Sandoz GmbH
Slovenian: Slovenija Sandoz GmbH
English: The Netherlands Aurobindo Pharma B.V.
Slovenian: Nizozemska Aurobindo Pharma B.V.
English: Bupropion Sandoz 300 mg tablete s prirejenim sproščanjem bupropion
Slovenian: Bupropion Sandoz 300 mg tablete s prirejenim sproščanjem bupropion tableta s prirejenim sproščanjem
English: Bupropion-neuraxpharm 300 mg Tabletten mit veränderter Wirkstofffreisetzung bupropion
Slovenian: Bupropion-neuraxpharm 300 mg Tabletten mit veränderter
English: 2care4 Aps
Slovenian: Danska 2care4 Aps
English: Naproxen 500 mg tablets naproxen
Slovenian: Naproxen 500 mg tablets naproksen
English: acide ursodesoxycholique Inopharm ursodeoxycholic acid 500 mg Film-coated tablet
Slovenian: acide ursodesoxycholique Inopharm ursodeoksiholna kislina 500 mg
English: PUREN Pharma GmbH & Co. KG
Slovenian: Nemčija PUREN Pharma GmbH & Co.
English: Cristers
Slovenian: Francija Cristers
English: Orion Corporation
Slovenian: Finska Orion Corporation
English: Oralcon 30 Microgramm/125 Microgramm Tabletten ethinylestradiol / levonorgestrel
Slovenian: Oralcon 30 Microgramm/125 Microgramm Tabletten etinilestradiol/levonorgestre l
English: Carbimazole 5mg Tablets carbimazole
Slovenian: Carbimazole 5mg Tablets karbimazol
English: Maexeni 30 0,03 mg/0,15 mg Filmtabletten ethinylestradiol / levonorgestrel mg/0.15 mg neuraxpharm Arzneimittel GmbH
Slovenian: Maexeni 30 0,03 mg/0,15 mg Filmtabletten etinilestradiol/levonorgestre l
English: Hydroxyzine ARROW hydroxyzine
Slovenian: Hydroxyzine ARROW hidroksizin
English: Metformin 1000 mg Filmcoated tablet metformin hydrochloride
Slovenian: Metformin 1000 mg Filmcoated tablet metforminijev hidroklorid 1 000 mg
English: 1 g
Slovenian: KG
English: Dawa Limited Carbimazole 5mg Tablets carbimazole
Slovenian: Dawa Limited Carbimazole 5mg Tablets karbimazol
English: Ethinylestradiol / Levonorgeshel Famy Care 30 mikrogramm 125 mikrogramm tablette ethinylestradiol / levonorgestrel
Slovenian: Ethinylestradiol / Levonorgeshel Famy Care 30 mikrogramm 125 mikrogramm tablette etinilestradiol/levonorgestre l
English: Bupropion Sandoz 300 mgTablette mit veränderter Wirkstofffreisetzung bupropion
Slovenian: Bupropion Sandoz 300 mgTablette mit veränderter Wirkstofffreisetzung bupropion tableta s prirejenim sproščanjem
English: Voriconazol Glob voriconazol
Slovenian: Voriconazol Glob vorikonazol
English: Naproxen Aurobindo 250 mg, tabletten
Slovenian: Naproxen Aurobindo 250 mg, tabletten naproksen
English: ZYDUS France perindopril/Indapamide Zydus France perindopril/indapamide 2 mg/ 0.625 mg
Slovenian: Francija ZYDUS France perindopril/Indapamide Zydus France perindopril/indapamid 2 mg/0,625 mg tableta
English: Vzole 200 mg film-coated tablets voriconazol
Slovenian: Vzole 200 mg film-coated tablets vorikonazol
English: Vzole 50 mg film-coated tablets voriconazol
Slovenian: Vzole 50 mg film-coated tablets vorikonazol
English: Omega 3 Strides Arcolab International omega-3-acid-ethyl esters 90
Slovenian: Omega 3 Strides Arcolab International omega-3-kislinski etilestri kapsula, mehka
English: Metformin 850 mg Film-coated tablet metformin hydrochloride
Slovenian: Metformin 850 mg Film-coated tablet metforminijev hidroklorid 850 mg
English: Naproxeno Aurobindo
Slovenian: Naproxeno Aurobindo naproksen
English: Voriconazolo Aurobindo voriconazol
Slovenian: Voriconazolo Aurobindo vorikonazol
English: ZYDUS France perindopril/Indapamide Zydus France perindopril/indapamide 4 mg / 1.25 mg
Slovenian: Francija ZYDUS France perindopril/Indapamide Zydus France perindopril/indapamid 4 mg/1,25 mg tableta
English: Voriconazole Milpharm 200 mg film-coated tablets voriconazol
Slovenian: Voriconazole Milpharm 200 mg film-coated tablets vorikonazol
English: Naproxen Aurobindo 500 mg, tabletten
Slovenian: Naproxen Aurobindo 500 mg, tabletten naproksen
English: United Kingdom HEC Pharm GmbH
Slovenian: Nemčija HEC Pharm GmbH
English: Levonorgestrel/Ethinylestradiol Famy Care 125 mikrogramů/30 mikrogramů ethinylestradiol / levonorgestrel
Slovenian: Levonorgestrel/Ethinylestradio l Famy Care 125 mikrogramů/30 mikrogramů etinilestradiol/levonorgestre l
English: Hydroxyzinhydrochlorid EQL Pharma hydroxyzine
Slovenian: Hydroxyzinhydrochlorid EQL Pharma hidroksizin
English: Voriconazole Milpharm 50 mg film-coated tablets voriconazol
Slovenian: Voriconazole Milpharm 50 mg film-coated tablets vorikonazol
English: Voriconazol Aurobindo 200 mg, filmomhulde tabletten voriconazol
Slovenian: Voriconazol Aurobindo 200 mg, filmomhulde tabletten vorikonazol
English: ZYDUS France perindopril/Indapamide Zydus France perindopril/indapamide 8 mg / 2.5 mg
Slovenian: Francija ZYDUS France perindopril/Indapamide Zydus France perindopril/indapamid 8 mg/2,5 mg tableta
English: Carbimazole 20 mg Tablets carbimazole
Slovenian: Carbimazole 20 mg Tablets karbimazol